The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -10,118 | -11,660 |
| Depreciation and amortization | 191 | 542 |
| Stock-based compensation | 137 | 452 |
| Loss on disposal of property and equipment | -507 | - |
| Change in fair value of convertible notes payable | 3,508 | -1,617 |
| Change in fair value of warrant liabilities | 231 | 103 |
| Accounts receivable, net | 2 | -39 |
| Inventory, net | -297 | -756 |
| Prepaid expenses and other current assets | -262 | 10 |
| Accounts payable | -288 | -1,526 |
| Accrued liabilities | 5,137 | -335 |
| Other accrued liabilities | 740 | 1,379 |
| Operating lease liabilities | 5 | 10 |
| Other long-term liabilities | -3,616 | - |
| Net cash used in operating activities | -3,009 | -11,867 |
| Purchases of property and equipment | 520 | 345 |
| Net cash used in investing activities | -520 | -345 |
| Effect of foreign currency translation on cash and cash equivalents | 2 | -174 |
| Net change in cash and cash equivalents | -3,527 | -12,386 |
| Cash and cash equivalents at beginning of period | 20,586 | - |
| Cash and cash equivalents at end of period | 4,673 | - |
Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. (ADGM)